Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism.

Ravikumar ShahVirendra PatilVijaya SarathiAnurag Ranjan LilaMargaret ZacharinBrijesh KrishnappaManjeetkaur SehembySanjeet Kumar JaiswalPratap L JadhavSwati Ramteke-JadhavNalini ShahTushar Bandgar

Published in: Pituitary (2020)

Prior-TRT may interfere with spermatogenic response to CGT in CHH patients, especially in those with a severe phenotype.

Keyphrases

replacement therapy
smoking cessation
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
early onset
prognostic factors
peritoneal dialysis
stem cells
mesenchymal stem cells
bone marrow